Catalyst Funds Management Pty »

Novabay Pharmaceuticals shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Novabay Pharmaceuticals shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Novabay Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Novabay Pharmaceuticals held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novabay Pharmaceuticals by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-03-31 $20k 14k 1.49

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Rio Tinto Adr (RIO)
Arm Holdings Adr (ARM)
Astrazeneca Ordinary Shares (AZN)
Medline Ordinary Shares (MDLN)
Cisco Systems Ordinary Shares (CSCO)
Abbvie Ordinary Shares (ABBV)
Teradyne Ordinary Shares (TER)
TechnipFMC Ordinary Shares (FTI)
Elbit Systems Ordinary Shares (ESLT)
Exxon Mobil Corp. Ordinary Shares (XOM)
Walmart Ordinary Shares (WMT)
Cheniere Energy Ordinary Shares (LNG)
Revolution Medicines Ordinary Shares (RVMD)
Valero Energy Corp. Ordinary Shares (VLO)

View all positions for Catalyst Funds Management Pty

Top funds holding Novabay Pharmaceuticals

BlackRock
Geode Capital Management
Vanguard Capital Management
Vanguard Fiduciary Trust
Jane Street
Two Sigma Investments
State of Wyoming
Schonfeld Strategic Advisors
Catalyst Funds Management Pty
Hrt Financial
Vanguard Global Advisers
Wells Fargo & Company
UBS Group
Morgan Stanley
NVWM

View all funds holding Novabay Pharmaceuticals